Achievements
Clinical and Translational Research Home for Georgia and Scientific Advances
From 2007 through 2023, this partnership has developed a Georgia home for clinical and translational research and has directly supported or contributed to 2,700 investigators with over 6,500 instances of program support including 1,450 from Georgia CTSA Clinical Research Centers (GCRCs), 1,200 from Biostatistics, Epidemiology, & Research Design (BERD) consults, and 600 from Informatics; 500 Pilot Grants awards with $20 million in pilot grant funding and over $143 million in follow-on funding; and 560 future clinical and translational scientists (MSCR, CPTR, KL2, and TL1 scholars or trainees). Direct support has also contributed to over 4,000 scientific publications.
Georgia CTSA's most recent direct support of breakthroughs in cutting-edge clinical and translational research:
Discovery
- Translation in Action: CTSA-Supported COVID-19 Work Yields High-Quality, Collaborative, Human-Centered Research Across the Translational Science Spectrum
- Research to Policy: Innovative Bibliometrics Reveal How CTSA Publications Advance Translation
- Georgia CTSA Integrating Special Populations’ Fishers of Men Initiative Implements CDC’s Diabetes Prevention Program
- Georgia CTSA Informatics Provides Support for Health Equity Data Sandbox Initiative
- Georgia CTSA Leaders Help Advance HIV/AIDS Research at NIH-funded Emory Clinical Trial Unit
- Georgia CTSA Clinical Research Centers Provide Critical Support for Challenge Studies Including Flu and Shigella
- Georgia CTSA’s AppHatchery Develops Georgia TB Reference Guide App as an Invaluable Resource for Clinical Care
- Georgia CTSA's AppHatchery Retools CCHD PulseOx Screening App to Improve Detection of Heart Defects in Newborns
- Georgia CTSA Clinical Research Centers (GCRCs) Provide Vital Support for Groundbreaking ANCHOR Study
- Study for New Type 1 Diabetes Treatment Co-Led by Georgia CTSA Principal Investigator
- Georgia CTSA Investigator’s Research Reveals Effect of Different Treatments for SARS-CoV-2 Infection
- Children’s Joins Forces with Georgia CTSA’s AppHatchery to Develop Nurse-Patient Communicator App
- Pilot Project by Georgia CTSA Leader and Collaborators Receives FDA Breakthrough Device Designation for PTSD Treatment
- Georgia CTSA Investigators Research Clinical Significance of Mental Stress-Induced Myocardial Ischemia in CHD Patients
- Georgia CTSA Informatics Co-Director Investigates Using AI to Improve Outcomes for Sepsis Patients
- Georgia CTSA Leaders Receive Nearly $20M NIH Grant as Part of Long COVID Nationwide Study
Training
- Georgia CTSA KL2 Scholar and Research Team Identify Crucial Biomarker That Tracks Recovery from Treatment-Resistant Depression
- Former Georgia CTSA UL1 Diversity Scholar to Lead Maternal Health Research Center of Excellence
- New Findings from Study Directed by Georgia CTSA CPTR Graduate Offer Potential Breakthrough in HIV Cure Research
- MSCR Graduate’s Research Examines Quality of Care for Veterans with Serious Artery Disease
- Former Georgia CTSA KL2 Scholar’s Research May Lead to Potential New Treatments for Patients with Depression
- Georgia CTSA KL2 Scholar Uses Cutting-Edge Techniques to Enhance Precision in Assessing Human Bone Health
- Former Georgia CTSA KL2 Scholar Andrea Sikora, PharmD, MSCR, Receives $1.86M to Use AI to Prevent Adverse Drug Events in ICU
- Georgia CTSA TL1 Trainee Focuses on Quality Improvement Initiatives to Reduce Postoperative Sepsis
- Georgia CTSA CPTR Graduate Wins NIH Challenge by Exploring Social Determinants of Health in Maternal Mortality and Morbidity
Community
- Georgia CTSA Community Engagement Health Educator Receives Standing Ovation Award
- Georgia CTSA Community Engagement and UGA Cooperative Extension Working Together to Advance Health Equity
- Grant Writing Academy Training for Community-Based Organizations
- Georgia CTSA Community Engagement’s CHWs and Allies at Georgia State Capitol on Community Health Workers Day
- NIH Spotlights Georgia CEAL’s Inter-Faith Alliance to Stop COVID-19
- ‘What’s Your Why?’ Georgia CEAL Ad Campaign to Reduce COVID-19 Vaccine Hesitancy
- Georgia CTSA Community Engagement Forum Highlights: Advancing Health Equity Amidst a New Normal
- Community and Academic Partner Database Connects Researchers to Improve Health
Pilot Grants
The Pilot Grants program has funded more than 500 projects totaling over $20 million in funding. The awards are divided between senior and junior PI investigators and are distributed across all CTSA partner institutions, spanning a spectrum of translational research topics.
Pilot Grant recipients have subsequently received $143 million in extramural funding as a result of the preliminary work funded by the Pilot Grants program. The Pilot Grants program has also led to the issuance of 12 new patents leading to innovative medical practices and technologies.
Clinical Research Sites
Georgia CTSA Clinical Research Centers (GCRCs) play an important role in the understanding of disease processes as well as the research and development of a wide variety of treatments and vaccines. The GCRCs across all our partner institutions have supported multiple, high-value research projects including the NIH-funded RECOVER study of long COVID. Notably, the GCRC at Morehouse School of Medicine (MSM) has the highest enrollment of diverse populations, specifically African American and Hispanic, across the entire study. The GCRC at Emory is supporting a novel challenge study to determine the safety and efficacy of a Shigella vaccine as well as important research to validate influenza challenge studies. The Clinical and Translational Research Unit (CTRU) at UGA is supporting a recently funded National Science Foundation Innovation Engine grant to advance health equity across Georgia. The CTRU continues to assist investigators in identifying rural counties to conduct community-engaged research.
The GCRC coordinator support services developed in the last few years have grown to support investigators in Surgery, Digestive diseases, Obstetrics & Gynecology, Pulmonary, and Infectious diseases departments at Emory. The coordinator pool plays an important role in the education and training of new Clinical Research Coordinators (CRC). MSM has developed a unique Clinical Research Coordinator certificate course with the aim of growing the CRC workforce in diverse populations. The Emory GCRC coordinator pool, UGA nursing team, and Emory core lab team successfully demonstrated the ability to provide cross-institutional support for the NIH-funded PreVail study, resulting in a quick response with support completed in less than one month.
GCRC Biorepository now includes samples for COVID-19, influenza, HPV, RSV, and Ebola convalescent samples available for diagnostic test validation. Requests for bionutrition services across the GCRCs has increased, for example, two new important feeding studies, the NIH-funded FEED-CF study in children and adults with cystic fibrosis and an NIH-funded study comparing the DASH diet with a control diet in individuals with heart failure.
Education & Training
Georgia CTSA Research Education programs include the Emory Master of Science in Clinical Research (MSCR), the Certificate Program in Translational Science (CPTS, recently renamed from Certificate Program in Translational Research to align with NIH focus), the KL2 (career development program for junior faculty focused on a career in clinical investigation), and TL1 program (supports predoctoral and postdoctoral clinical and translational research training). The Georgia CTSA-supported MSCR program has had 258 graduates with a Master of Science (MSc) degree including predoctoral and postdoctoral trainees, resident and fellow physicians, and junior faculty at Emory. MSCR graduates have had more than 5,400 peer-reviewed publications. The Georgia CTSA Research Education MSCR students and graduates have served as principal investigators on 166 NIH awards totaling $267 million. Currently, there are 22 first-year MSCR students who will start in Fall 2023, and 23 second-year students. The CPTS program has 96 students who have completed the program and there are 38 current CPTS students, including 19 students who will start in Fall 2023. The KL2 program has had 68 junior faculty KL2 scholars since the inception of the Georgia CTSA as well as three UL1 Diversity Supplement scholars. Approximately 70% of the KL2 scholars who have completed the program have obtained a federal grant (most commonly from NIH) as Principal Investigator (PI); 69% of the scholars have been women. The TL1 Predoctoral and Postdoctoral training program has had 147 TL1 trainees since the inception of the CTSA.
Pediatrics
Pediatrics continues to build a citywide infrastructure for expanded pediatric-focused clinical and translational research within the Georgia CTSA academic institutional partnerships. Research facilitation and the conduct of pediatric studies increased by over 25%, including a Metabolic Camp where medical care was provided to pediatric patients. Expanded services available to investigators include developmental pediatrics, allergy/immunology, psychology, and nursing.
The Pediatric Research Unit now provides pulmonary function testing, Ultrasound-guided IV placement, phlebotomy-only visits, and space utilization in addition to IDS and nursing services. In 2022 the Pediatric Research unit at the Center for Advanced Pediatrics completed 1146 visits representing 3715 of hours serviced for pediatric research. The Pediatric Research unit at CAP currently services approximately 50 active pediatric studies and an additional 50 studies which are pending enrollment.
The PRU saw 30 patients for Metabolic Camp in June 2023 for the first time since 2019. The PRU has seen patients for Metabolic Camp for a number of years. Metabolic Camp serves Girls with PKU and MSUD helping to provide valuable research for these patients. The camp provides a supportive environment for adolescent girls and women to learn about the importance of nutrition and diet self-management, with the intention of arresting the disease process and minimizing the instances of miscarriages and severe birth defects, which are high in this population. In July 2023 the Pediatric Research Unit began seeing patients for children allergic to peanuts. The VITESSE trial is studying the efficacy of a new type of patch that can be used to help desensitize children with severe peanut allergies. Other current treatments consist of Oral immune therapy or injections. Dr. Brian Vickery is the PI for the trial and currently has 6 allergy trials being seen in the PRU.
Pediatrics sponsored the Southeastern Pediatric Research Conference attended by hundreds of individuals from across the U.S., including all four partner institutions. At MSM, Pediatrics hosted the Annual HeLa Women's Health Symposium. For families, Pediatrics sponsored the KIDS booth at the Atlanta Science Festival.
Innovation Catalyst
Innovation Catalyst accelerates health technology through engagement, education, and outreach. Innovation Catalyst’s primary initiative, AppHatchery, takes simple mobile app ideas through strategy, user research, visual and user experience design, development, and minimal viable product (MVP) clinical study. Since 2019, the AppHatchery has launched a dozen digital health projects for both patients and clinicians in collaboration with several partners including Children’s Healthcare of Atlanta and Grady Memorial Hospital. Several projects are in the development pipeline tackling diabetes management, implicit bias training, allergy identification, and nurse/patient translation and communication. AppHatchery has authored multiple academic journal publications, presents posters at conferences, and collaborates on grant proposals with investigators. The Innovation Catalyst program also provides early-stage entrepreneur consulting and training to academic investigators who have limited experience with commercialization through its InnovationTrailhead initiative, and guidance on how to write SBIR/STTR grants through the BizGrants initiative. View and download some of the available applications below:
Informatics
The Georgia CTSA Informatics Core supports Emory investigators and the wider Georgia research community through the Georgia CTSA by obtaining access, curating data, analyzing data, and creating novel informatics and AI/ML solutions for single or multi-center studies. Each of the services may be tailored to fit the individual needs of each investigator. In addition, Informatics supports mHealth initiatives such as the Moyo Health Network, Health Equity Data Sandbox, and Real-Time Analytics, which provides valuable data. The Informatics team continues to support Emory’s research data warehouse and MSM’s i2b2 research data warehouse. Informatics at Georgia Tech supports OneFlorida, All of Us, ACT, RECOVER, NCATS: National COVID Cohort Collaborative (N3C), and TriNetX, which runs phenotypes locally and provides results for secure aggregate analysis.
In the latest science advancements, the EPIC ecosystem, Application Programming Interface (APIs), and migrated pipelines have enabled data extraction to match our prior capabilities with CDW and new data types (e.g., Echo results). The RTA platform can now readily support additional AI/ML models and analysis, using AWS serverless computation for scaling up and out. The adoption of OMOP and Emory’s migration to EPIC enables the sharing and adoption of standard tools at all Georgia CTSA clinical sites. In FY 2022, the Informatics Core supported 19 unique projects, contributing to 638 support hours. The Georgia CTSA Informatics Lunch and Learn speaker series is designed to allow informatics experts to engage with the community about the exciting new work they are completing in informatics. The Informatics experts explain in detail the understanding of the medical content area and the informatics techniques.
Regulatory Knowledge & Support
The Regulatory Knowledge & Support program has led to enhancements of clinical research efficiencies through the establishment of institutional agreements, such as the IRB Reciprocity, Intellectual Property (IP), and Data Use agreements. The Online Ethics Center includes over 40 ethical dilemmas in scientific research and expert opinions in PDF and podcast formats, and we are exploring additional opportunities for disseminating this unique offering.
Regulatory Knowledge & Support also facilitated the adaption of the UGA School of Pharmacy online course for the Emory online learning system and worked with the UGA College of Engineering to create a five-year BS/MS that will lead to Pharmaceutical Engineering specialization. The program’s efforts are also supported by the UGA Institute for International Biomedical Regulatory Sciences (IBRS), which is the home of the UGA graduate education programs in the regulatory sciences and clinical trials management. This program is the only comprehensive regulatory program in the United States that covers all major biomedical product categories (Pharmaceuticals, Devices, Biologics, Animal Health, and Combination Products) in the context of the US FDA and other major international regulatory agencies. The program also actively responds to major information requests from Georgia CTSA investigators related to the regulatory processes of manufacturing and filing for multiple types of medical devices overseen by the FDA.
Community Engagement
Community Engagement launched a 3-tier system of support for the community to facilitate relationships among diverse stakeholders that work together to advance population health. Community Engagement mini-grants were recently funded for children of incarcerated parents, food insecurity, and opioid use/risk reduction. View a complete list of Georgia CTSA Community Engagement Funded Organizations from 2017-2021.
Capacity building workshops were held for community members across the state that provided culturally and contextually competent training on:
- How to Establish and Maintain 501(3) Non-Profit Status
- Two-day Grant Writing Crash Course
In addition, the 4th Annual Biennial Community Engagement Forum provided participants with the tools necessary to develop and sustain successful and mutually beneficial community-university partnerships to increase public health in Atlanta and beyond.
View the community engagement infographic
Partnerships
Creation of activities, such as the Southeast Regional Clinical & Translational Science Conference, that build strong partnerships with the private, non-profit Georgia Bio (encompassing the Georgia biotechnology community), Biolocity (formerly named the Coulter Foundation), and the state-sponsored Georgia Research Alliance to produce synergies that foster and accelerate new and emerging technologies and discoveries.
Expansion of existing synergistic partnership with Yerkes National Primate Research Center on informatics, animal models, and educational opportunities.
Development of a growing partnership with the Winship Cancer Institute, a designated NCI Cancer Center, and collaborative efforts with Winship in genomics, a phase I clinical trials unit, joint pilot grants, and synergy with the Georgia Cancer Coalition and the Atlanta headquartered American Cancer Society.
Development of healthcare partnerships with the largest healthcare networks in Georgia including - Emory Healthcare, Children's, Morehouse Medical Associates, Grady Health System, and the Atlanta Veterans Affairs Medical Center.
Success Stories
Search Science Advance and Spotlight stories of success past and present